Asia accounted for approximately 45% of the global breast cancer cases in 2020, with Mainland China, India, and Japan contributing the majority of cases.

Other relevant content

September 1, 2023 Report

Nasopharyngeal Carcinoma: Global Clinical Trial Landscape

Download
August 28, 2023 Report

Gallbladder Cancer: Global Clinical Trial Landscape

Download
June 26, 2023 Report

Liver Cancer Global Clinical trial landscape- Focus on Asia Pacific

Download
May 26, 2023 Report

Non-Hodgkin Lymphoma Global Clinical trial Landscape- Focus on Asia Pacific

Download
August 25, 2019 Case Study

Rescue study and Oncology CRO services. Local know-how gets pivotal breast cancer trial back on…

Read More
September 5, 2023 Whitepaper

Rare Disease – Global Clinical Trial Landscape (2018-2022)

Download
June 2, 2023 Whitepaper

Oncolytic Virus Therapies– Global Clinical Trial Landscape - Focus On Asia Pacific

Download
May 2, 2023 Whitepaper

RNA Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific

Download
June 14, 2023 Webinar

Endpoints at ASCO23: How to accelerate development in novel & advanced oncology therapies — from…

Watch
May 26, 2023 News

Novotech Sponsors Oncology Summit with eChina Health and Expert Panel on Drug Development…

Read more Notification Icon
June 2-6, 2023 Events

ASCO Annual Meeting (In Person)

Chicago

Read More
Expertise Icon
  Expertise

Oncology CRO services

Expertise Icon